These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19654004)

  • 1. Endogenous cortisol 6 beta-hydroxylation clearance is not an accurate probe for overall cytochrome P450 3A phenotyping in humans.
    Hu ZY; Zhao YS; Wu D; Cheng ZN
    Clin Chim Acta; 2009 Oct; 408(1-2):92-7. PubMed ID: 19654004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.
    Luo X; Li XM; Hu ZY; Cheng ZN
    Acta Pharmacol Sin; 2009 Sep; 30(9):1323-9. PubMed ID: 19701237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects.
    Woolsey SJ; Beaton MD; Choi YH; Dresser GK; Gryn SE; Kim RB; Tirona RG
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):284-91. PubMed ID: 26399557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers.
    Krupka E; Venisse N; Lafay C; Gendre D; Diquet B; Bouquet S; Perault MC
    Eur J Clin Pharmacol; 2006 Aug; 62(8):653-9. PubMed ID: 16832678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans.
    Furuta T; Suzuki A; Mori C; Shibasaki H; Yokokawa A; Kasuya Y
    Drug Metab Dispos; 2003 Nov; 31(11):1283-7. PubMed ID: 14570755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese.
    Chan SW; Xiao Y; Hu M; Yin OQ; Chu TT; Fok BS; Lee VH; Tomlinson B
    J Clin Pharm Ther; 2016 Oct; 41(5):552-8. PubMed ID: 27511886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-dependent differences in cytochrome P450 3A activity as assessed by midazolam disposition in humans: a meta-analysis.
    Hu ZY; Zhao YS
    Drug Metab Dispos; 2010 May; 38(5):817-23. PubMed ID: 20164111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
    Xue X; Huang M; Xiao H; Qin X; Huang L; Zhong G; Bi H
    J Pharm Biomed Anal; 2011 Apr; 55(1):187-93. PubMed ID: 21316177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.
    Streetman DS; Kashuba AD; Bertino JS; Kulawy R; Rocci ML; Nafziger AN
    Pharmacogenetics; 2001 Jun; 11(4):349-55. PubMed ID: 11434513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
    Zhu B; Ou-Yang DS; Cheng ZN; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2001 Jul; 22(7):634-8. PubMed ID: 11749829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity.
    Hu Z; Gong Q; Hu X; Wang L; Cao Y; Cao W; Yu Q; Cheng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):238-43. PubMed ID: 16183337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity.
    Shimizu M; Uno T; Tamura HO; Kanazawa H; Murakami I; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):275-81. PubMed ID: 17085083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females.
    Lee J; Kim AH; Yi S; Lee S; Yoon SH; Yu KS; Jang IJ; Cho JY
    AAPS J; 2017 Jul; 19(4):1196-1204. PubMed ID: 28523515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
    Thummel KE; Shen DD; Podoll TD; Kunze KL; Trager WF; Hartwell PS; Raisys VA; Marsh CL; McVicar JP; Barr DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):549-56. PubMed ID: 7965755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 6β-hydroxycortisol to cortisol ratio as a less invasive cytochrome P450 3A phenotyping method.
    Hirano R; Yokokawa A; Furihata T; Shibasaki H
    Br J Clin Pharmacol; 2024 Apr; 90(4):1016-1026. PubMed ID: 38102865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and quantitative determination of 6α-hydroxycortisol and 6β-hydroxycortisol in human urine by high-performance liquid chromatography with ultraviolet absorption detection.
    Shibasaki H; Okamoto S; Inoue R; Okita M; Yokokawa A; Furuta T
    Anal Bioanal Chem; 2012 Mar; 402(9):2945-52. PubMed ID: 22318698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach.
    Shin KH; Ahn LY; Choi MH; Moon JY; Lee J; Jang IJ; Yu KS; Cho JY
    AAPS J; 2016 Sep; 18(5):1254-1261. PubMed ID: 27317471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited sampling models for oral midazolam: midazolam plasma concentrations, not the ratio of 1-hydroxymidazolam to midazolam plasma concentrations, accurately predicts AUC as a biomarker of CYP3A activity.
    Lee LS; Bertino JS; Nafziger AN
    J Clin Pharmacol; 2006 Feb; 46(2):229-34. PubMed ID: 16432275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.